Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CAMMA', Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.837
EU - Europa 4.281
AS - Asia 1.131
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 10
OC - Oceania 8
AF - Africa 7
Totale 19.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.820
IT - Italia 1.405
CN - Cina 910
FI - Finlandia 846
UA - Ucraina 556
IE - Irlanda 339
DE - Germania 324
GB - Regno Unito 272
RU - Federazione Russa 138
SE - Svezia 125
RO - Romania 92
IN - India 60
FR - Francia 58
TR - Turchia 55
BE - Belgio 36
KR - Corea 34
HK - Hong Kong 24
NL - Olanda 18
CA - Canada 17
CH - Svizzera 14
CZ - Repubblica Ceca 12
EU - Europa 9
IR - Iran 9
AT - Austria 8
ES - Italia 8
PL - Polonia 8
JP - Giappone 7
UZ - Uzbekistan 7
AU - Australia 6
GR - Grecia 6
LB - Libano 5
PK - Pakistan 4
SG - Singapore 4
BG - Bulgaria 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
NG - Nigeria 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BR - Brasile 2
CO - Colombia 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EC - Ecuador 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
MD - Moldavia 1
MY - Malesia 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 19.285
Salva come PNG Salva come JPEG
Città #
Fairfield 2.562
Ashburn 1.271
Woodbridge 1.235
Chandler 1.099
Houston 955
Seattle 951
Wilmington 935
Cambridge 825
Ann Arbor 671
Palermo 414
Dublin 339
Jacksonville 305
Medford 304
Altamura 226
Des Moines 218
Nanjing 198
Princeton 188
Lawrence 173
San Diego 128
New York 108
Boardman 91
Dearborn 91
Tulsa 85
Beijing 84
Jinan 75
Shenyang 73
Nanchang 66
London 55
Hebei 53
Izmir 50
Jiaxing 47
Ludwigshafen am Rhein 47
Changsha 43
Milan 43
Tianjin 43
Saint Petersburg 38
Ningbo 37
Brussels 36
Zhengzhou 34
Kumar 32
Seongnam 30
Bremen 29
Verona 28
Los Angeles 27
Venice 27
Falls Church 25
San Paolo di Civitate 25
Hangzhou 24
Taizhou 20
Guangzhou 19
Phoenix 19
Pune 19
Auburn Hills 18
Orange 17
Lanzhou 16
Redwood City 16
Helsinki 15
Kilburn 15
Düsseldorf 14
San Mateo 14
West Jordan 14
Rome 12
Haikou 11
Chicago 10
Hong Kong 10
Kunming 10
Ottawa 10
Washington 10
Central 9
Taiyuan 9
Edinburgh 8
Indiana 8
Moscow 8
Redmond 8
Tappahannock 8
Fuzhou 7
Hefei 7
Hounslow 7
Napoli 7
Aragona 6
Barcellona Pozzo di Gotto 6
Den Haag 6
Imola 6
Norwalk 6
Tehran 6
Acton 5
Amsterdam 5
Atlanta 5
Brno 5
Chiswick 5
Hanover 5
Madrid 5
Toronto 5
Vicopisano 5
Catania 4
Central District 4
Clearwater 4
Giugliano in Campania 4
Salerno 4
Seoul 4
Totale 14.923
Salva come PNG Salva come JPEG
Nome #
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 199
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 190
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 189
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 188
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. 182
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 179
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 174
Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response 171
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 168
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. 167
Treatment of hepatocellular carcinoma: present and future. 164
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 159
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. 158
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 154
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease 150
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 149
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C 149
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 149
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. 147
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation 146
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 144
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS 143
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 142
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 142
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 141
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. 139
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems 137
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 136
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection 136
Clinical implications of the hyperdynamic syndrome in cirrhosis. 135
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. 134
Causes of and prevention strategies for hepatocellular carcinoma. 134
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 133
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease 133
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 133
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort 133
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 130
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 130
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. 129
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 129
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. 128
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C 128
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients 127
Hyperferritinemia is a risk factor for steatosis in chronic liver disease. 127
Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. 126
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 126
Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial 125
Transjugular Intrahepatic Portosystemic Shunt For Refractory Ascites: A Meta-Analysis Of Individual Patient Data 125
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 125
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 125
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 125
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. 125
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis 124
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study 124
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing 124
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 124
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy 123
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data 122
THE COMPLEX INTERPLAY BETWEEN VITAMIN D DEFICIENCY AND DIABETES 122
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C 121
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C 121
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies 121
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years 121
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data 120
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 120
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 120
Treatment of hepatitis C: critical appraisal of the evidence 119
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C 119
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD 119
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 119
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 118
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values 118
Prevention of hepatocellular carcinoma 117
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 117
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 117
When and how to treat acute hepatitis C? 117
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach 115
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. 115
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy 115
CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants 115
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 115
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis 114
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study 114
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 114
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C 114
Assessment of treatment response in hepatocellular carcinoma: a review of literature 113
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model 113
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. 112
Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C 112
Treating patients with HCV genotype 1 and low viraemia: more than meets the eye 111
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 111
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner 110
Unsatisfactory quality of hepatological information on the internet 110
Genetic predisposition to thrombophilia in inflammatory bowel disease 110
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study 110
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance 108
Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply 107
Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. 107
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use 107
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. 106
Totale 13.122
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.402 0 0 0 0 0 0 0 0 0 249 615 538
2019/20205.966 586 259 318 622 644 729 646 456 675 315 545 171
2020/20213.065 184 258 185 297 261 164 192 237 342 395 259 291
2021/20222.423 178 522 62 68 66 98 137 142 297 249 189 415
2022/20233.136 338 663 44 352 306 484 176 211 382 17 110 53
2023/20241.028 52 205 67 88 89 300 115 59 22 31 0 0
Totale 20.141